Treatment of electronic cigarette or vaping product use‐associated lung injury (EVALI) by corticosteroid and low‐dose pirfenidone: Report of a case

Treatment of electronic cigarette or vaping product use‐associated lung injury (EVALI) by corticosteroid and low‐dose pirfenidone: Report of a case

Abstract Electronic (e)‐cigarette or vaping product use‐associated lung injury (EVALI) is a novel and potentially lethal disease first reported in the United States. We report the case of a 56‐year‐old man who presented to our hospital with dyspnoea and cough lasting for 2 months after using an e‐ci...

Full description

Bibliographic Details
Main Authors: Chia‐Hao Wu, Ting‐Yu Liao, Yung‐Hsuan Chen, Ping‐Hung Kuo
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Respirology Case Reports
Subjects:
corticosteroid
e‐cigarette or vaping product use associated lung injury (EVALI)
organizing pneumonia
pirfenidone
Online Access:https://doi.org/10.1002/rcr2.845

Similar Items

Similar Items